Deuterx
Get Full AccessDescription
- DeuteRx is a virtual, clinical stage biopharmaceutical company focused on improving racemic drugs for patients. The team has pioneered the use of deuterium to chiral switch drugs that are a mixture of interconverting stereoisomers. This approach has been applied to >15 APIs at 2 companies since 2010. The lead product assets are DRX-065 for adrenomyeloneuropathy (AMN) and nonalcoholic steatohepatitis (NASH) and DRX-164 for hematologic malignancies and solid tumors. The 1st company, Deuteria Pharmaceuticals, Inc. was acquired by Celgene in 2012.
-
Headquarters:300 Brickstone Square Suite 201, Andover, Massachusetts, United States
More -
Phone Number: +1 978-662-5287
-
Website: https://www.deuterx.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Deuterx
-
Deuterx's Social Media
-
Is this data correct?
-
| NAICS Code: 325412 |
Show More
Sell more in less time!
Buyer intent data, anonymous visitor identification, first party data integration backed by a massive contact database that will supercharge your sales team. Schedule a demo to learn more!
Frequently Asked Questions regarding Deuterx
-
Where are Deuterx's Headquarters?
Deuterx's Headquarters are in 300 Brickstone Square Suite 201,Andover,Massachusetts,United States
-
What is Deuterx's phone number?
Deuterx's phone number is +1 978-662-5287
-
What is Deuterx's official website?
Deuterx's official website is https://www.deuterx.com
-
What is Deuterx's Revenue?
Deuterx's revenue is $1 - 10M
-
What is Deuterx's NAICS code?
Deuterx's NAICS code is 325412
-
How many employees are working in Deuterx
Deuterx has 6 employees
-
What is Deuterx's Industry?
Deuterx is in the industry of Biotechnology
-
Who is Deuterx's CEO?
Deuterx's CEO is Mary D.Wallace